Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 11/20 | 0.60 |
| ▸ | MEN1 | O00255 | 5/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | LMNA | P02545 | 5/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MMP14 | P50281 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11776089 | 0.98 | SMN1; SMN2 (0.71) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11330090 | 0.88 | SMN1; SMN2 (0.69) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11776076 | 0.88 | SMN1; SMN2 (0.69) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11317722 | 0.85 | SMN1; SMN2 (0.62) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11330097 | 0.84 | SMN1; SMN2 (0.68) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11327656 | 0.84 | SMN1; SMN2 (1.00) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL7827861 | 0.82 | SMN1; SMN2 (0.52) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11325695 | 0.81 | SMN1; SMN2 (1.00) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11318200 | 0.81 | SMN1; SMN2 (0.67) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL11327907 | 0.81 | SMN1; SMN2 (0.67) | SMN1; SMN2NPC1RAB9AHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0530559-B1 | Process for the preparation of 1-nitroanthraquinone-2-carboxylic acid | BASF AG (DE) | 1995-10-18 | — | — | EP | claimed |
| US-5245058-A | PREPARATION OF 1-NITROANTHRAQUINONE-2-CARBOXYLIC ACIDS | BASF AKTIENGESELLSCHAFT (DE) | 1993-09-14 | — | — | US | claimed |
| EP-0371362-B1 | PROCESS FOR THE PREPARATION OF 1-NITRO, 2-CARBOXY-ANTHRAQUINONE | BASF Aktiengesellschaft (DE) | 1993-02-03 | — | — | EP | claimed |
| US-4950756-A | OXIDATION OF 2-SUBSTITUTED 1-NITROANTHRAQUINONE | BASF AKTIENGESELLSCHAFT (DE) | 1990-08-21 | — | — | US | claimed |
| EP-0021264-B1 | PROCESS FOR THE DELIGNIFICATION OF LIGNOCELLULOSIC MATERIALS | BAYER AG (DE) | 1983-01-19 | — | — | EP | claimed |
| EP-0005206-B1 | METHOD OF PREPARING 1,4-DIAMINOANTHRAQUINONE-2-CARBOXYLIC ACID | CIBA-GEIGY AG (CH) | 1981-04-01 | — | — | EP | claimed |
| US-4250102-A | Process for the manufacture of aminohydroxyanthraquinones | CIBA-GEIGY AG (CH) | 1981-02-10 | — | — | US | claimed |
| EP-0021264-A1 | Process for the delignification of lignocellulosic materials | BAYER AG (DE) | 1981-01-07 | — | — | EP | claimed |
| US-4243600-A | Process for the manufacture of 1,4-diaminoanthraquinone-2-carboxylic acid | CIBA-GEIGY AG (CH) | 1981-01-06 | — | — | US | claimed |
| US-4198518-A | Process for the production of 3-substituted pyrazolanthrones | CIBA-GEIGY CORPORATION (US) | 1980-04-15 | — | — | US | claimed |
| US-4046785-A | Process for preparing aminoanthraquinones | MITSUI TOATSU CHEMICALS, INC. (JA) | 1977-09-06 | — | — | US | claimed |
| JP-2184657-A | — | — | None | — | — | JP | disclosed |
| JP-5194329-A | — | — | None | — | — | JP | disclosed |
| US-20260117284-A1 | REDOX LABELED OLIGONUCLEOTIDE PROBES AND THEIR USE | ABBOTT DIAGNOSTICS SCARBOROUGH INC | 2026-04-30 | — | — | US | disclosed |
| EP-4556571-A2 | REDOX LABELED OLIGONUCLEOTIDE PROBES AND THEIR USE | Abbott Diagnostics Scarborough, Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| US-4202696-A | Method of removing surface tack of cured free radical polymerized resin composition using organic carbonyl compound | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-05-13 | — | — | US | disclosed |
| US-4198518-A | Process for the production of 3-substituted pyrazolanthrones | CIBA-GEIGY CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| US-4046785-A | Process for preparing aminoanthraquinones | MITSUI TOATSU CHEMICALS, INC. (JA) | 1977-09-06 | — | — | US | disclosed |
| US-4016182-A | Process for the production of aminoanthraquinone compounds | SANDOZ LTD. (CH) | 1977-04-05 | — | — | US | disclosed |
| US-4006171-A | FROM NITROANTHRAQUINONE AND HALOGEN | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117284-A1 | REDOX LABELED OLIGONUCLEOTIDE PROBES AND THEIR USE | POLRMT, SQOR, MTHFD1 | SMN1; SMN2 3703/4885NPC1 4809/4885RAB9A 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.